Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Beijing HuiLongGuan Hospital
With
Peking University
Tardive dyskinesia(TD) is a common complication of conventional antipsychotic treatment in subjects with schizophrenia. There is no established treatment for TD patients.This disorder remains a significant clinical problem for both patients and physicians for the foreseeable future.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female aged 18 to 60yrs
Meeting Diagnostic and Statistical Manual of Mental Diseases, Fourth Edition(DSM-IV) criteria for schizophrenia or schizo-affective disorder
Abnormal Involuntary Movement Scale (AIMS) score ≥2.
Patients from whom informed, written consent is obtained.
Patients who have been on a fixed dose of antipsychotic medication for at least 4 weeks prior to trial entry.
You may not be if
Significant neurological disorder other than TD
Substance abuse
Significant other medical illness
Psychiatric disorder not stabilised
Pregnancy or lactation
Take antioxidants(such as Vitamin C)
Clareo Health | Extract of Ginkgo Biloba and Tardive Dyskinesia
